Joseph D. Ceccoli is an Independent Director of the Company. Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC, a bioscience company located at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization of skin-active molecules and treatment products used in regulated (OTC / Med-care), personal care and consumer products. Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and the world’s largest global chemical company, where he was responsible for the integration, operations and growth of domestic and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a US based fortune 500 company and chief operating officer of the Long Island based Collaborative Group from 2004 to 2007. Mr. Ceccoli holds a Bachelor of Science Degree in Biotechnology from Rochester Institute of Technology and advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists.
Joseph Ceccoli is 52, he's been the Independent Director of Applied Dna Sciences Inc since 2014. There are 8 older and 6 younger executives at Applied Dna Sciences Inc. The oldest executive at Applied Dna Sciences Inc is Robert Catell, 80, who is the Director.
Joseph's mailing address filed with the SEC is 50, Health Sciences Drive, Stony Brook University, Suffolk, New York, 11794, United States.
Over the last 22 years, insiders at Applied Dna Sciences Inc have traded over $13,655,198 worth of Applied Dna Sciences Inc stock and bought 12,115,698 units worth $17,246,871 . The most active insiders traders include Management Inc Rhl, Lawrence Lee a Dwyer Management Inc O. On average, Applied Dna Sciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $312,035. The most recent stock trade was executed by Scott L Anchin on 10 March 2021, trading 13,049 units of APDN stock currently worth $110,003.
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Applied Dna Sciences Inc executives and other stock owners filed with the SEC include: